Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form.
D000293:Adolescent; D000328:Adult; D001796:Blood Protein Disorders / Q000188:drug therapy* / Q000235:genetics; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013256:Steroids / Q000378:metabolism; D014973:Xanthomatosis / Q000209:etiology
D008074:Lipoproteins; D009539:Nicotinic Acids; D013256:Steroids; D002792:Cholestyramine Resin; D002784:Cholesterol